Physician profile
Ryan T Chartrand
NPI 1720341894
$9,628.23
in general payments reported to CMS, 2019-2025
47 companies · $1,867 in 2025
The $1,867 reported for 2025 was more than what 78% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,248 · 2020: $560 · 2021: $1,117 · 2022: $749 · 2023: $737 · 2024: $1,350 · 2025: $1,867.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,854 · Education: $99.96.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,853.98 |
| Education | $99.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neotract INC. | $2,826.60 | 2019-2020 | |
| Abbvie INC. | $733.42 | 2019-2025 | Lupron Depot, Botox |
| Astellas Pharma US INC | $593.82 | 2019-2025 | Xtandi |
| Teleflex LLC | $507.37 | 2021-2025 | Urolift, Barrigel |
| Merck Sharp & Dohme LLC | $397.87 | 2019-2025 | Keytruda, Lynparza, Keytruda Qlex |
| Urogen Pharma, INC. | $356.26 | 2023-2025 | Jelmyto |
| Dendreon Pharmaceuticals LLC | $321.34 | 2021-2025 | Provenge |
| Tolmar Pharmaceuticals, INC. | $302.32 | 2019-2022 | |
| Pfizer INC. | $282.20 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $255.45 | 2020-2025 | Lynparza |
| Boston Scientific Corporation | $253.39 | 2020-2025 | Spaceoar Vue System - 10ml, Rezum Generator |
| Accord Healthcare, INC. | $245.34 | 2022-2025 | |
| Janssen Biotech, INC. | $239.62 | 2021-2025 | Erleada, Akeega |
| Coloplast Corp | $235.44 | 2021-2025 | Altis, Speedicath |
| Allergan, INC. | $186.30 | 2019-2022 |
Show all 47 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Chartrand listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.